Voiding Time for the Evaluation of Lower Urinary Tract Symptoms in Men – A Potential Option for Addressing Disparity Related Access to Urodynamic Testing



      To investigate voiding time (VT) in asymptomatic and symptomatic men, and compare VT to other parameters such as maximum flow rates (Qmax) as a possible solution to disparity related lack of access to standard urodynamic testing.


      We conducted a controlled prospective study on a total of 30 patients. Exclusion criteria included ongoing medical therapy for lower urinary tract symptoms (LUTS) or a history of invasive therapy for LUTS. Patients completed International Prostate Symptom Score (IPSS) questionnaire, uroflowmetry, and post-void residual (PVR) testing. Symptomatic LUTS was defined as an IPSS ≥8.


      On univariate analysis, men with a symptomatic LUTS had a significantly longer VT than asymptomatic men (30.6 seconds (Interquartile rage [IQR] 24.2-42.4) vs 20.5 seconds (IQR 16.6-40.5), P = .04). VT was not otherwise associated with age, race, or primary complaint. There was trend towards lower Qmax in symptomatic patients (13.4 vs 20.5 seconds, P = .07), although this was not statistically significant. Our study demonstrated that the sensitivity of a VT ≥23.5 seconds, or probability of observing a VT exceeding 23.5 seconds when the patient has a symptomatic IPSS, is 85%. On sensitivity and specificity analysis, there was no difference between the abilities of VT and Qmax to predict that a patient would have symptomatic LUTS (P = .80).


      In this controlled prospective study, we found that VT was as accurate as Qmax in predicting symptomatic IPSS scores. This novel finding might improve the ability to diagnose and treat LUTS, especially in primary care offices and underserved areas.


      LUTS (lower urinary tract symptoms), VT (voiding time), AUA (American Urological Association), IPSS (International Prostate Symptoms Score), Qmax (maximum flow rate), Qmean (mean flow rate), PVR (post void residual), BPH (benign prostatic hyperplasia)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Irwin DE
        • Kopp ZS
        • Agatep B
        • et al.
        Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence, and bladder outlet obstruction.
        BJU Int. 2011; 108: 1132-1138
        • Launer BM
        • McVary KT
        • Ricke WA
        • et al.
        The rising wordwide impact of benign prostatic hyperplasia.
        BJU Int. 2021; 127: 722
        • Lerner LB
        • McVary KT
        • Barry MJ
        • et al.
        Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline part I, initial work-up and medical management.
        J Urol. 2021; 206: 806
      1. Yang PJ, Pham JC, Choo J et al. Law of Urination: all mammals empty their bladders over the same duration. 2013. arXiv:1310.37370

        • Sorel MR
        • Reitsma HJB
        • Rosier PFWM
        • et al.
        Uroflowmetry in healthy women: a systematic review.
        Neurourol Urodyn. 2017; 36: 953-959
        • Kim JH
        Updated meta-analysis on normal uroflowmetry data in healthy women.
        Neurourol Urodyn. 2017; 36: 1952-1953
        • Barry MJ
        • Fowler FJ
        • O'Leary MP
        • et al.
        The american urological association symptom index for benign prostatic hyperplasia. The measurement committee of the american urological association.
        J Urol. 1992; 148: 1549
        • Chancellor MB
        • Blaivas JG
        • Kaplan SA
        • et al.
        Bladder outlet obstruction vs impaired detrusor contractility: the role of outflow.
        J Urol. 1991; 145: 810-812
        • Wada N
        • Watanabe M
        • Ishikawa M
        • et al.
        Uroflowmetry pattern in detrusor underactivity and bladder outlet obstruction in male patients with lower urinary tract symptoms.
        Low Urin Tract Symptoms. 2021; 13: 361-365
        • Nitti VM
        Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction.
        Rev Urol. 2005; 7: S14-S21